NCT07031219
HIV/HBV/HCV Triple Screening in Primary Care
At risk: Primary completion moved at least 6 months later.
See at-risk trials from University of Texas Southwestern Medical Center
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 6 versions: 6 with changes below. See every version on ClinicalTrials.gov ↗
Notable Primary and study completion pushed from Jun 2027 to Dec 31, 2027 Show 5 more changesShow less
- Recruitment opened
- Start date: Jun 1, 2026 to Nov 1, 2026
- Eligibility criteria expanded, about 10 words
- Secondary endpoints: details revised at 5 of 5 entries
- Site details revised
- Notable Start date: Feb 15, 2026 to Jun 1, 2026v5
Notable Start date: Jan 1, 2026 to Feb 15, 2026v4 Show 5 more changesShow less
- Eligibility criteria expanded, about 35 words
- Primary and study completion dates: May 31, 2027 to Jun 2027
- Interventions: provider order set/order panel (Other) to electronic medical record alert linked to orders (Other)
- Secondary endpoints revised (5)
- Study arms: 2 to 1
- Notable Start date: Aug 1, 2025 to Jan 1, 2026
- Primary and study completion dates: Dec 31, 2027 to May 31, 2027
- Minor Secondary endpoints: 3 to 5v2
- Study First Submitted
- Notable: the plan changed
- Minor: routine updates
Endpoints
Primary
Secondary (5)
Arms and interventions
For participating providers, each of their encounters will be randomized to either control (no alert; no changes to EMR interface; standard of care) or intervention (alert linked to triple testing orders will trigger when the provider attempts to order a screening test for HIV, hepatitis B, or hepatitis C). Since randomization will occur at the encounter level, participating providers will randomly experience control and intervention encounters throughout the duration of the study.
Other: electronic medical record alert linked to orders
Sites
1 site in 1 country
- University of Texas Southwestern Medical CenterDallas, Texas, United States